Kodiak Sciences Inc (KOD)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

1200 PAGE MILL RD PALO ALTO, CA 94304

Kodiak Sciences Inc. operates as a clinical stage biopharmaceutical company. The Company specializes in novel therapeutics to treat chronic and high-prevalence retinal diseases. Kodiak Sciences serves customers in the Unites States.

Data as of 2020-11-22
Market Cap6.272 Billion Shares Outstanding44.803 Million Avg 30-day Volume506.738 Thousand
P/E Ratio-60.3 Dividend Yield EPS-2.32
Price/Sales Price cash flow ratio Price free cash flow ratio-212.8
Book Value6.29 Price to Tangible Book22.26 Alpha0.13
Short Interest Ratio % Short Interest to Float R-squared0.039029
BETA1.18118 52-week High/Low141.98 / 24.41 Stddev0.350944
View SEC Filings from KOD instead.
Q3 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 3 4 -25.0% 2 (0.13%) 3 (0.19%) -33.33%
Funds Holding: 134 124 8.06% 40 (2.63%) 38 (2.47%) 5.26%
13F shares: 36.836 Million 38.196 Million -3.56% 22.031 Million 23.347 Million -5.64%
% Ownership 82.3848 85.8634 -4.05% 49.2722 52.4831 -6.12%
New Positions: 28 28 0.0% 8 12 -33.33%
Increased Positions 45 53 -15.09% 16 12 33.33%
Closed Positions 15 11 36.36% 6 7 -14.29%
Reduced Positions 43 25 72.0% 12 9 33.33%
Total Calls 71.552 Thousand 60.052 Thousand 19.15% 13.1 Thousand 19.1 Thousand -31.41%
Total Puts 355.098 Thousand 37.9 Thousand 836.93% 273.885 Thousand 13.1 Thousand 1990.73%
PUT/CALL Ratio 4.96 0.63 687.3% 20.91 0.69 2930.43%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding KOD (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding KOD BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

1.5 Million total shares from 2 transactions

Open Market Sells (S)

36.1 Thousand total shares from 16 transactions

Exercise Derivative Conversion (M)

48.9 Thousand total shares from 6 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

BAKER BROS. ADVISORS LP

667, L.P.

BAKER BROS. ADVISORS (GP) LLC

BAKER BROTHERS LIFE SCIENCES LP

BAKER FELIX

BAKER JULIAN

  • Director
  • 10% Owner
13,879,952 2020-11-20 10

EHRLICH JASON SEE REMARKS

  • Officer
42,843 2020-11-20 19

DAHIYAT BASSIL I

  • Director
0 2020-06-30 2

PROFUSEK ROBERT

  • Director
0 2020-06-30 2

LEVY RICHARD S

  • Director
0 2020-06-30 3

PERLROTH VICTOR CHAIRMAN, PRESIDENT AND CEO

  • Officer
  • Director
  • 10% Owner
0 2020-06-30 2

BORGESON JOHN A. SEE REMARKS

  • Officer
0 2020-06-30 2

YANG TAIYIN

  • Director
0 2020-06-30 3

BANCROFT CHARLES A

  • Director
0 2020-06-30 3

LIANG HONG SVP, DISCOVERY MEDICINE

  • Officer
130,166 2020-04-02 4

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

BAKER BROS. ADVISORS LP - Director - > 10% Owner see footnotes

667, L.P. - Director - > 10% Owner see footnotes

BAKER BROS. ADVISORS (GP) LLC - Director - > 10% Owner see footnotes

BAKER BROTHERS LIFE SCIENCES LP - Director - > 10% Owner see footnotes

BAKER FELIX - Director - > 10% Owner see footnotes

BAKER JULIAN - Director - > 10% Owner see footnotes

2020-11-24 16:09:52 -0500 2020-11-20 P 116,158 $108.00 a 1,143,396 indirect 2.118 2.118 2 0.0 1

EHRLICH JASON - Officer SEE REMARKS

2020-11-24 18:04:23 -0500 2020-11-20 S 2,614 $139.96 d 42,900 direct yes 2.118 2.118 2 0.0 1

EHRLICH JASON - Officer SEE REMARKS

2020-11-24 18:04:23 -0500 2020-11-20 S 400 $137.27 d 48,629 direct yes 2.118 2.118 2 0.0 1

EHRLICH JASON - Officer SEE REMARKS

2020-11-24 18:04:23 -0500 2020-11-20 M 6,950 $10.29 a 49,793 direct 2.118 2.118 2 0.0 1

EHRLICH JASON - Officer SEE REMARKS

2020-11-24 18:04:23 -0500 2020-11-20 M 6,950 d 338,675 direct

EHRLICH JASON - Officer SEE REMARKS

2020-11-24 18:04:23 -0500 2020-11-20 S 2,134 $139.39 d 45,514 direct yes 2.118 2.118 2 0.0 1

EHRLICH JASON - Officer SEE REMARKS

2020-11-24 18:04:23 -0500 2020-11-20 S 259 $134.72 d 49,029 direct yes 2.118 2.118 2 0.0 1

BAKER BROS. ADVISORS LP - Director - > 10% Owner see footnotes

667, L.P. - Director - > 10% Owner see footnotes

BAKER BROS. ADVISORS (GP) LLC - Director - > 10% Owner see footnotes

BAKER BROTHERS LIFE SCIENCES LP - Director - > 10% Owner see footnotes

BAKER FELIX - Director - > 10% Owner see footnotes

BAKER JULIAN - Director - > 10% Owner see footnotes

2020-11-24 16:09:52 -0500 2020-11-20 P 1,411,619 $108.00 a 12,736,556 indirect 2.118 2.118 2 0.0 1

EHRLICH JASON - Officer SEE REMARKS

2020-11-24 18:04:23 -0500 2020-11-20 S 57 $140.88 d 42,843 direct yes 2.118 2.118 2 0.0 1

EHRLICH JASON - Officer SEE REMARKS

2020-11-24 18:04:23 -0500 2020-11-20 S 981 $138.56 d 47,648 direct yes 2.118 2.118 2 0.0 1

EHRLICH JASON - Officer SEE REMARKS

2020-11-24 18:04:23 -0500 2020-11-20 S 505 $133.71 d 49,288 direct yes 2.118 2.118 2 0.0 1

EHRLICH JASON - Officer SEE REMARKS

2020-10-29 16:49:30 -0400 2020-10-27 M 7,500 $10.29 a 50,343 direct 0.2533 19.5793 19.5793 6 0.0 1

EHRLICH JASON - Officer SEE REMARKS

2020-10-29 16:49:30 -0400 2020-10-27 M 7,500 d 345,625 direct

EHRLICH JASON - Officer SEE REMARKS

2020-10-29 16:49:30 -0400 2020-10-27 S 7,500 $100.00 d 42,843 direct yes 0.2533 19.5793 19.5793 6 0.0 1

EHRLICH JASON - Officer SEE REMARKS

2020-10-27 16:57:50 -0400 2020-10-23 M 7,500 $10.29 a 50,343 direct 4.0684 7.8135 7.8135 6 -5.2681 3

EHRLICH JASON - Officer SEE REMARKS

2020-10-27 16:57:50 -0400 2020-10-23 M 7,500 d 353,125 direct

EHRLICH JASON - Officer SEE REMARKS

2020-10-27 16:57:50 -0400 2020-10-23 S 7,500 $86.25 d 42,843 direct yes 4.0684 7.8135 7.8135 6 -5.2681 3

EHRLICH JASON - Officer SEE REMARKS

2020-10-22 16:56:20 -0400 2020-10-20 S 3,397 $77.88 d 46,057 direct yes 0.031 -6.023 3.2392 5 -6.023 6

EHRLICH JASON - Officer SEE REMARKS

2020-10-22 16:56:20 -0400 2020-10-20 M 6,950 d 360,625 direct

EHRLICH JASON - Officer SEE REMARKS

2020-10-22 16:56:20 -0400 2020-10-20 S 339 $76.53 d 49,454 direct yes 0.031 -6.023 3.2392 5 -6.023 6

EHRLICH JASON - Officer SEE REMARKS

2020-10-22 16:56:20 -0400 2020-10-20 S 3,214 $79.13 d 42,843 direct yes 0.031 -6.023 3.2392 5 -6.023 6

EHRLICH JASON - Officer SEE REMARKS

2020-10-22 16:56:20 -0400 2020-10-20 M 6,950 $10.29 a 49,793 direct 0.031 -6.023 3.2392 5 -6.023 6

EHRLICH JASON - Officer SEE REMARKS

2020-10-15 17:44:12 -0400 2020-10-13 M 5,000 d 367,575 direct

EHRLICH JASON - Officer SEE REMARKS

2020-10-15 17:44:12 -0400 2020-10-13 S 5,000 $75.00 d 42,843 direct yes 1.3335 26.3302 78.677 83.0305 26 0.0 1

EHRLICH JASON - Officer SEE REMARKS

2020-10-15 17:44:12 -0400 2020-10-13 M 5,000 $10.29 a 47,843 direct 1.3335 26.3302 78.677 83.0305 26 0.0 1

EHRLICH JASON - Officer SEE REMARKS

2020-10-13 19:04:46 -0400 2020-10-09 M 15,000 a 48,984 direct 1.5621 5.1802 76.502 86.9159 28 0.0 1

EHRLICH JASON - Officer SEE REMARKS

2020-10-13 19:04:46 -0400 2020-10-09 M 15,000 d 0 direct

EHRLICH JASON - Officer SEE REMARKS

2020-10-13 19:04:46 -0400 2020-10-09 S 553 $69.91 d 44,490 direct yes 1.5621 5.1802 76.502 86.9159 28 0.0 1

EHRLICH JASON - Officer SEE REMARKS

2020-10-13 19:04:46 -0400 2020-10-09 S 896 $72.14 d 42,843 direct yes 1.5621 5.1802 76.502 86.9159 28 0.0 1

EHRLICH JASON - Officer SEE REMARKS

2020-10-13 19:04:46 -0400 2020-10-09 F 3,941 $71.25 d 45,043 direct 1.5621 5.1802 76.502 86.9159 28 0.0 1

EHRLICH JASON - Officer SEE REMARKS

2020-10-13 19:04:46 -0400 2020-10-09 S 751 $71.27 d 43,739 direct yes 1.5621 5.1802 76.502 86.9159 28 0.0 1

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments